Advanced Cancer Screening
Advanced cancer screening by Circulating Tumor Cells (CTC) involves the detection and analysis of cancer cells that have shed from a primary tumor and entered the bloodstream. This method allows for the non-invasive monitoring of cancer progression and treatment response. By capturing and analyzing CTCs from a blood sample, healthcare providers can gain valuable insights into the genetic mutations and characteristics of the cancer, helping to guide personalized treatment decisions.
